Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 308Recruiting 249Unknown 138Terminated 59Active not recruiting 55Not yet recruiting 43Withdrawn 32Enrolling by invitation 6Suspended 2

Sponsor Class

OTHER 6

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Myeloid 1Lymphoid 1Head & Neck 1CNS 1Breast 1

Conditions

Neoplasms 2Parkinsonian Disorders 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Myelitis, Transverse 1Myasthenia Gravis 1Multiple Sclerosis 1Lymphoproliferative Disorders 1Hematologic Diseases 1Head and Neck Neoplasms 1Glioma 1Breast Neoplasms 1Autoimmune Diseases 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Fluorodeoxyglucose F18 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Enrolling by invitation × Blood Specimen Collection × Clear all
NCT00704626 2026-05-18

SAA

University of California, Davis

Enrolling by invitation
120 enrolled

Autoimmune Diseases, Multiple Sclerosis, Myasthenia Gravis, Myelitis, Transverse

NCT04202094 2026-05-06

Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems

Universitair Ziekenhuis Brussel

Phase NA Enrolling by invitation
50 enrolled

Hematologic Diseases, Neoplasms

NCT07542158 2026-04-21

Ultralow Dose PET Imaging of 18F-FDOPA

Nuclear Imaging Institute

Phase 2 Enrolling by invitation
200 enrolled
CNS

Glioma, Neoplasms, Parkinsonian Disorders

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

OHSU Knight Cancer Institute

Enrolling by invitation
5,000 enrolled
LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT01173341 2026-02-09

Cardiotoxicity of Cancer Therapy (CCT)

Abramson Cancer Center at Penn Medicine

Enrolling by invitation
700 enrolled
Breast

Breast Neoplasms

NCT06809673 2025-02-05

PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial

Ospedale Policlinico San Martino

Enrolling by invitation
400 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡